Stem Cells Spin Spolka Akcyjna Logo

Stem Cells Spin Spolka Akcyjna

Biotech firm commercializing proprietary MIC-1 stem cells through R&D, cultivation, and production.

SCS | WAR

Overview

Corporate Details

ISIN(s):
PLSTCLS00013 (+2 more)
LEI:
259400ZBL6DOUA86FW60
Country:
Poland
Address:
WROCŁAW KONOPNICKIEJ 15B, 51-141 WROCŁAW
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Stem Cells Spin Spolka Akcyjna is a biotechnology company specializing in the commercialization of proprietary inventions related to MIC-1 stem cells. The company's core activities include the research, development, cultivation, and production of these unique stem cells and their derivative substances. Based on discoveries by scientists at the Medical University of Wroclaw, the company focuses on leveraging its innovative cultivation methods and patents to bring stem cell-based products to market. Its business model centers on monetizing its intellectual property through further development and commercial applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-07 14:53
Share Issue/Capital Change
Podpisanie listu intencyjnego z inwestorem - Content (PL)
Polish 1.4 KB
2025-06-30 10:15
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 723 bytes
2025-06-04 19:37
M&A Activity
Zawarcie umowy o zachowaniu poufności (NDA) w celu przeprowadzenia badania due …
Polish 1.3 KB
2025-05-30 13:51
Declaration of Voting Results & Voting Rights Announcements
liczba głosów i akcji w spółce
Polish 684.5 KB
2025-05-30 13:51
Proxy Solicitation & Information Statement
wzór pełnomocnictwa
Polish 2.3 MB
2025-05-30 13:51
Post-Annual General Meeting Information
projekty uchwał
Polish 941.6 KB
2025-05-30 13:51
Pre-Annual General Meeting Information
ogłoszenie o zwołaniu ZWZ
Polish 807.6 KB
2025-05-30 13:51
Pre-Annual General Meeting Information
Zwołanie Zwyczajnego Walnego Zgromadzenia Spółki na 26 czerwca 2025 roku - Cont…
Polish 805 bytes
2024-12-23 20:53
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Nadzwyczajnym Walnym…
Polish 726 bytes
2024-11-22 19:34
Regulatory News Service
Otrzymanie przez Marka Cegielskiego - członka Rady Nadzorczej tytułu profesora …
Polish 1.2 KB
2024-11-22 14:22
Declaration of Voting Results & Voting Rights Announcements
informacja i liczbie akcji i głosów
Polish 684.5 KB
2024-11-22 14:22
Proxy Solicitation & Information Statement
wzór pełnomocnictwa
Polish 2.4 MB
2024-11-22 14:22
Post-Annual General Meeting Information
projekty uchwał
Polish 1.2 MB
2024-11-22 14:22
Pre-Annual General Meeting Information
treść ogłoszenia o zwołaniu NWZ
Polish 806.7 KB
2024-11-22 14:22
Pre-Annual General Meeting Information
Zwołanie Nadzwyczajnego Walnego Zgromadzenia Spółki na 19 grudnia 2024 roku - C…
Polish 793 bytes

Automate Your Workflow. Get a real-time feed of all Stem Cells Spin Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Stem Cells Spin Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Stem Cells Spin Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan 2449
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America 950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel PPBT
QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden QUIA
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea 115180
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan 4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan 6098
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan 4889

Talk to a Data Expert

Have a question? We'll get back to you promptly.